Literature DB >> 8448340

Determination of atrazine metabolites in human urine: development of a biomarker of exposure.

A D Lucas1, A D Jones, M H Goodrow, S G Saiz, C Blewett, J N Seiber, B D Hammock.   

Abstract

Enzyme-linked immunosorbent assays (ELISAs) are reported for the detection of atrazine and its principle metabolite in human urine. The ELISAs can be used with crude urine or following extraction and partial purification by methods described in this report. GC, MS, and HPLC techniques were used to confirm and complement the ELISA methods for qualitative and quantitative detection of urinary metabolites. A series of samples from workers applying this herbicide confirmed a mercapturic acid conjugate of atrazine as a major urinary metabolite. The mercapturate was found in concentrations at least 10 times that of any of the N-dealkylated products or the parent compound. Atrazine mercapturic acid was isolated from urine using affinity extraction based upon a polyclonal antibody for hydroxy-s-triazines and yielded products sufficiently pure for structure confirmation by MS/MS. In a pilot study monitoring applicators, a relationship between cumulative dermal and inhalation exposure and total amount of atrazine equivalents excreted over a 10-day period was observed. On the basis of these data, we propose that an ELISA for the mercapturate of atrazine could be developed as a useful marker of exposure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448340     DOI: 10.1021/tx00031a017

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  9 in total

1.  Two-dimensional high performance liquid chromatography separation and tandem mass spectrometry detection of atrazine and its metabolic and hydrolysis products in urine.

Authors:  Zsuzsanna Kuklenyik; Parinya Panuwet; Nayana K Jayatilaka; James L Pirkle; Antonia M Calafat
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-06-02       Impact factor: 3.205

2.  Dopaminergic toxicity of the herbicide atrazine in rat striatal slices.

Authors:  Nikolay M Filipov; Molly A Stewart; Russell L Carr; Shannon C Sistrunk
Journal:  Toxicology       Date:  2006-12-15       Impact factor: 4.221

3.  Urinary biomonitoring for alachlor exposure in commercial pesticide applicators by immunoassay.

Authors:  R E Biagini; W Tolos; W T Sanderson; G M Henningsen; B MacKenzie
Journal:  Bull Environ Contam Toxicol       Date:  1995-02       Impact factor: 2.151

4.  Quantum Dots as Reporters in Multiplexed Immunoassays for Biomarkers of Exposure to Agrochemicals.

Authors:  M Nichkova; D Dosev; A E Davies; S J Gee; I M Kennedy; B D Hammock
Journal:  Anal Lett       Date:  2007-01       Impact factor: 2.329

5.  In vitro atrazine exposure affects the phenotypic and functional maturation of dendritic cells.

Authors:  Lesya M Pinchuk; Sang-Ryul Lee; Nikolay M Filipov
Journal:  Toxicol Appl Pharmacol       Date:  2007-06-21       Impact factor: 4.219

6.  Disposition of the herbicide 2-chloro-4-(ethylamino)-6-(isopropylamino)-s-triazine (Atrazine) and its major metabolites in mice: a liquid chromatography/mass spectrometry analysis of urine, plasma, and tissue levels.

Authors:  Matthew K Ross; Toni L Jones; Nikolay M Filipov
Journal:  Drug Metab Dispos       Date:  2008-12-30       Impact factor: 3.922

7.  Presence of atrazine in the biological samples of cattle and its consequence adversity in human health.

Authors:  Sz Peighambarzadeh; S Safi; Sj Shahtaheri; M Javanbakht; A Rahimi Forushani
Journal:  Iran J Public Health       Date:  2011-12-31       Impact factor: 1.429

8.  Assessing exposure to atrazine and its metabolites using biomonitoring.

Authors:  Dana B Barr; Parinya Panuwet; Johnny V Nguyen; Simeon Udunka; Larry L Needham
Journal:  Environ Health Perspect       Date:  2007-10       Impact factor: 9.031

Review 9.  Occupational pesticide exposures and respiratory health.

Authors:  Ming Ye; Jeremy Beach; Jonathan W Martin; Ambikaipakan Senthilselvan
Journal:  Int J Environ Res Public Health       Date:  2013-11-28       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.